GGrantIndex
← Search

RIVUR Clinical Trial

$33,500Y01FY2012DKNIH

National Institute Of Diabetes And Digestive And Kidney Diseases

Investigators

Abstract

This study is a randomized, double-blind, placebo-controlled trial of the trimethoprim sulfamethoxazole (TMP/SMZ) suspension in children with vesicoureteral reflux. The study is designed to recruit 600 children (approximately 300 in each treatment group) and follow them 24 months.

View original record on NIH RePORTER →
RIVUR Clinical Trial · GrantIndex